Search
Targeting Spike‐ACE2 Interface of SARS‐CoV‐2 and its Omicron Variant: A Comparative Screening of Potential Inhibitors for Existing and Anticipating Variants Using Molecular Modelling Approach
Abstract
The recent COVID pandemic has shown major impact on public health and economic crisis. Despite the development of many vaccines and drugs against the severe acute respiratory syndrome (SARS) coronavirus 2, the pandemic still persists. The continued spread of the virus is largely driven by the emergence of viral variants such as α, β, γ, delta, epsilon spike, omicron and its subvariants (BA.1,2,3) which can evade the current vaccines through mutations in the spike protein.[1] For instance, spike to omicron has modifications at different mutations (D405N, K417N, S477N, E484A, Q493R, N501Y, Y505H).[1b] These mutations will affect functional properties and hence may alter the specificity towards potential drug candidates. Therefore, it is important to understand the role of these mutations on interactions with existing drug candidates. In this study, we focus on the two forms of SARS-CoV-2, such as wild-type spike and omicron and unveil their interactions with different drugs. For this purpose, we have taken about hundred drugs categorised in twelve groups of anticancer, natural products, enzyme inhibitors, antivirals, antioxidants, anti-bacterials, anti-malarials, antidiabetics, antimicrobials, anti-inflammatory, antifungals and other drugs. We used in-silico methods to understand the effect of these drug molecules on wild type and omicron spike RBD at the interface of ACE2 enzyme. Based on molecular docking results, we have chosen 7 best docked compounds and studied their interaction patterns in detail by molecular dynamics simulation.
Citations
-
1
CrossRef
-
0
Web of Science
-
1
Scopus
Authors (6)
-
Dineshbabu Takkella
-
Sudhanshu Sharma
-
Ashok Pabbathi
-
Krishna Gavvala
Cite as
Full text
full text is not available in portal
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
ChemistrySelect
no. 8,
pages 1 - 13,
ISSN: 2365-6549 - Language:
- English
- Publication year:
- 2023
- Bibliographic description:
- Takkella D., Sharma S., Krzemieniecki R., Pabbathi A., Sappati S., Gavvala K.: Targeting Spike‐ACE2 Interface of SARS‐CoV‐2 and its Omicron Variant: A Comparative Screening of Potential Inhibitors for Existing and Anticipating Variants Using Molecular Modelling Approach// ChemistrySelect -Vol. 8,iss. 32 (2023),
- DOI:
- Digital Object Identifier (open in new tab) 10.1002/slct.202302687
- Sources of funding:
-
- IDUB
- Verified by:
- Gdańsk University of Technology
seen 66 times
Recommended for you
Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants
- W. Ezzemani,
- A. Kettani,
- S. Sappati
- + 8 authors
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
- U. Kalathiya,
- M. Padariya,
- M. Mayordomo
- + 11 authors
Biochemical, Structural Analysis, and Docking Studies of Spiropyrazoline Derivatives
- A. Adamus-Grabicka,
- M. Daśko,
- P. Hikisz
- + 3 authors